Neurological Disorder Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014575057
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Neurological Disorder Drugs in global, including the following market information:
Global Neurological Disorder Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Neurological Disorder Drugs Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Neurological Disorder Drugs companies in 2020 (%)
The global Neurological Disorder Drugs market was valued at 19820 million in 2020 and is projected to reach US$ 22730 million by 2027, at a CAGR of 3.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurological Disorder Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurological Disorder Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Neurological Disorder Drugs Market Segment Percentages, By Type, 2020 (%)
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others

Global Neurological Disorder Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Neurological Disorder Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic

Global Neurological Disorder Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Neurological Disorder Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurological Disorder Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Neurological Disorder Drugs revenues share in global market, 2020 (%)
Key companies Neurological Disorder Drugs sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Neurological Disorder Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
GlaxoSmithKline
Merck & Co.
Bayer
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceutical

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Neurological Disorder Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurological Disorder Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurological Disorder Drugs Overall Market Size
2.1 Global Neurological Disorder Drugs Market Size: 2021 VS 2027
2.2 Global Neurological Disorder Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Neurological Disorder Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Neurological Disorder Drugs Players in Global Market
3.2 Top Global Neurological Disorder Drugs Companies Ranked by Revenue
3.3 Global Neurological Disorder Drugs Revenue by Companies
3.4 Global Neurological Disorder Drugs Sales by Companies
3.5 Global Neurological Disorder Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Neurological Disorder Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Neurological Disorder Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurological Disorder Drugs Players in Global Market
3.8.1 List of Global Tier 1 Neurological Disorder Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurological Disorder Drugs Market Size Markets, 2021 & 2027
4.1.2 Antipsychotic
4.1.3 Hypnotic & Sedative
4.1.4 Analgesics
4.1.5 Anticoagulants
4.1.6 Others
4.2 By Type - Global Neurological Disorder Drugs Revenue & Forecasts
4.2.1 By Type - Global Neurological Disorder Drugs Revenue, 2016-2021
4.2.2 By Type - Global Neurological Disorder Drugs Revenue, 2022-2027
4.2.3 By Type - Global Neurological Disorder Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Neurological Disorder Drugs Sales & Forecasts
4.3.1 By Type - Global Neurological Disorder Drugs Sales, 2016-2021
4.3.2 By Type - Global Neurological Disorder Drugs Sales, 2022-2027
4.3.3 By Type - Global Neurological Disorder Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Neurological Disorder Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurological Disorder Drugs Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Neurological Disorder Drugs Revenue & Forecasts
5.2.1 By Application - Global Neurological Disorder Drugs Revenue, 2016-2021
5.2.2 By Application - Global Neurological Disorder Drugs Revenue, 2022-2027
5.2.3 By Application - Global Neurological Disorder Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Neurological Disorder Drugs Sales & Forecasts
5.3.1 By Application - Global Neurological Disorder Drugs Sales, 2016-2021
5.3.2 By Application - Global Neurological Disorder Drugs Sales, 2022-2027
5.3.3 By Application - Global Neurological Disorder Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Neurological Disorder Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Neurological Disorder Drugs Market Size, 2021 & 2027
6.2 By Region - Global Neurological Disorder Drugs Revenue & Forecasts
6.2.1 By Region - Global Neurological Disorder Drugs Revenue, 2016-2021
6.2.2 By Region - Global Neurological Disorder Drugs Revenue, 2022-2027
6.2.3 By Region - Global Neurological Disorder Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Neurological Disorder Drugs Sales & Forecasts
6.3.1 By Region - Global Neurological Disorder Drugs Sales, 2016-2021
6.3.2 By Region - Global Neurological Disorder Drugs Sales, 2022-2027
6.3.3 By Region - Global Neurological Disorder Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Neurological Disorder Drugs Revenue, 2016-2027
6.4.2 By Country - North America Neurological Disorder Drugs Sales, 2016-2027
6.4.3 US Neurological Disorder Drugs Market Size, 2016-2027
6.4.4 Canada Neurological Disorder Drugs Market Size, 2016-2027
6.4.5 Mexico Neurological Disorder Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Neurological Disorder Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Neurological Disorder Drugs Sales, 2016-2027
6.5.3 Germany Neurological Disorder Drugs Market Size, 2016-2027
6.5.4 France Neurological Disorder Drugs Market Size, 2016-2027
6.5.5 U.K. Neurological Disorder Drugs Market Size, 2016-2027
6.5.6 Italy Neurological Disorder Drugs Market Size, 2016-2027
6.5.7 Russia Neurological Disorder Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Neurological Disorder Drugs Market Size, 2016-2027
6.5.9 Benelux Neurological Disorder Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Neurological Disorder Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Neurological Disorder Drugs Sales, 2016-2027
6.6.3 China Neurological Disorder Drugs Market Size, 2016-2027
6.6.4 Japan Neurological Disorder Drugs Market Size, 2016-2027
6.6.5 South Korea Neurological Disorder Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Neurological Disorder Drugs Market Size, 2016-2027
6.6.7 India Neurological Disorder Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Neurological Disorder Drugs Revenue, 2016-2027
6.7.2 By Country - South America Neurological Disorder Drugs Sales, 2016-2027
6.7.3 Brazil Neurological Disorder Drugs Market Size, 2016-2027
6.7.4 Argentina Neurological Disorder Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neurological Disorder Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Neurological Disorder Drugs Sales, 2016-2027
6.8.3 Turkey Neurological Disorder Drugs Market Size, 2016-2027
6.8.4 Israel Neurological Disorder Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Neurological Disorder Drugs Market Size, 2016-2027
6.8.6 UAE Neurological Disorder Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Neurological Disorder Drugs Major Product Offerings
7.1.4 Novartis Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Neurological Disorder Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.2.5 GlaxoSmithKline Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Neurological Disorder Drugs Major Product Offerings
7.3.4 Merck & Co. Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Merck & Co. Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Neurological Disorder Drugs Major Product Offerings
7.4.4 Bayer Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Bayer Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Neurological Disorder Drugs Major Product Offerings
7.5.4 AstraZeneca Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Neurological Disorder Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Boehringer Ingelheim Key News
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Corporate Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Neurological Disorder Drugs Major Product Offerings
7.4.4 Teva Pharmaceutical Neurological Disorder Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Teva Pharmaceutical Key News
8 Global Neurological Disorder Drugs Production Capacity, Analysis
8.1 Global Neurological Disorder Drugs Production Capacity, 2016-2027
8.2 Neurological Disorder Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurological Disorder Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neurological Disorder Drugs Supply Chain Analysis
10.1 Neurological Disorder Drugs Industry Value Chain
10.2 Neurological Disorder Drugs Upstream Market
10.3 Neurological Disorder Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neurological Disorder Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Neurological Disorder Drugs in Global Market
Table 2. Top Neurological Disorder Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Neurological Disorder Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Neurological Disorder Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Neurological Disorder Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Neurological Disorder Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Neurological Disorder Drugs Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Neurological Disorder Drugs Product Type
Table 9. List of Global Tier 1 Neurological Disorder Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE